Organization

Sharp HealthCare

1 clinical trial

1 abstract

Clinical trial
NICU Antibiotics and Outcomes Follow-Up Study
Status: Not yet recruiting, Estimated PCD: 2029-03-01
Abstract
Phase 1 study of pritumumab in brain cancer.
Org: Pacific Neuroscience Institute and Saint John’s Cancer Institute at Providence Saint John’s Health Center, Saint John's Cancer Institute at Providence Saint John's Health Center, Nascent Biotech, Inc., Sharp HealthCare, Gilman Biosciences,